Literature DB >> 11254815

Statement on malignant mesothelioma in the United Kingdom.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254815      PMCID: PMC1746025          DOI: 10.1136/thorax.56.4.250

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  51 in total

1.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Authors:  D J Sugarbaker; R M Flores; M T Jaklitsch; W G Richards; G M Strauss; J M Corson; M M DeCamp; S J Swanson; R Bueno; J M Lukanich; E H Baldini; S J Mentzer
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

2.  Thioridazine in the management of cancer-related sweating.

Authors:  J Cowap; J Hardy
Journal:  J Pain Symptom Manage       Date:  1998-05       Impact factor: 3.612

3.  Finger clubbing in malignant mesothelioma and benign asbestos pleural disease.

Authors:  C McGavin; P Hughes
Journal:  Respir Med       Date:  1998-04       Impact factor: 3.415

4.  Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.

Authors:  G W Middleton; I E Smith; M E O'Brien; A Norton; T Hickish; K Priest; L Spencer; S Ashley
Journal:  Ann Oncol       Date:  1998-03       Impact factor: 32.976

Review 5.  Peritoneal mesothelioma.

Authors:  C G Moertel
Journal:  Gastroenterology       Date:  1972-08       Impact factor: 22.682

Review 6.  Pharmacological treatment of cachexia: any progress?

Authors:  E Bruera
Journal:  Support Care Cancer       Date:  1998-03       Impact factor: 3.603

7.  Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer.

Authors:  M Bredin; J Corner; M Krishnasamy; H Plant; C Bailey; R A'Hern
Journal:  BMJ       Date:  1999-04-03

8.  Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma.

Authors:  M B Jackson; D Pounder; C Price; A W Matthews; E Neville
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

9.  The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer.

Authors:  B Amesbury; J O'Riordan; S Dolin
Journal:  Palliat Med       Date:  1999-03       Impact factor: 4.762

Review 10.  CT and MR in pleural disease.

Authors:  T C McLoud
Journal:  Clin Chest Med       Date:  1998-06       Impact factor: 2.878

View more
  14 in total

1.  Radical surgery for mesothelioma.

Authors:  Tom Treasure; David Waller; Simon Swift; Julian Peto
Journal:  BMJ       Date:  2004-01-31

2.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

3.  Parasternal lymph node metastasis of malignant peritoneal mesothelioma: report of a case.

Authors:  Shinya Ito; Noritaka Isowa; Mio Li; Seiki Hasegawa; Hiromi Wada
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 4.  Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.

Authors:  Andrew R Haas; Daniel H Sterman
Journal:  Clin Chest Med       Date:  2013-01-17       Impact factor: 2.878

Review 5.  Management options for malignant pleural mesothelioma: clinical and cost considerations.

Authors:  Ranjit K Goudar
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma.

Authors:  J Green; Y Dundar; S Dodd; R Dickson; T Walley
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

7.  Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma.

Authors:  Ranjit K Goudar
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

8.  Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?

Authors:  Andrew J Drain; Kourosh Saeb-Parsy; Amit K Shah; D Rassl; Andrew J Ritchie
Journal:  J Cardiothorac Surg       Date:  2006-11-01       Impact factor: 1.637

9.  Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.

Authors:  Martin F Muers; Richard J Stephens; Patricia Fisher; Liz Darlison; Christopher M B Higgs; Erica Lowry; Andrew G Nicholson; Mary O'Brien; Michael Peake; Robin Rudd; Michael Snee; Jeremy Steele; David J Girling; Matthew Nankivell; Cheryl Pugh; Mahesh K B Parmar
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

10.  A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma.

Authors:  S Bydder; M Phillips; D J Joseph; F Cameron; N A Spry; Y DeMelker; A W Musk
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.